Skip to main content
SpringerLink
Log in

Aldosterone to Renin Ratio as a Predictor of Diuretic Response

  • CLINICAL TRIAL REPORTS
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lim PO, Jung RT, MacDonald TM: Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone. A prospective cohort follow-up study. Br J Clin Pharmacol 1999, 48:756–760.

    Article  CAS  PubMed  Google Scholar 

  2. Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315–318.

    Article  CAS  PubMed  Google Scholar 

  3. Mahmud A, Mahgoub M, Hall M, et al.: Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Am J Hypertens 2005, 18:1631–1635.

    Article  CAS  PubMed  Google Scholar 

  4. Montori VM, Young WF Jr: Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 2002, 31:619–632.

    Article  CAS  PubMed  Google Scholar 

  5. Stowasser M, Gordon RD: The aldosterone-renin ratio for screening for primary aldosteronism. The Endocrinologist 2004, 14:267–276.

    Article  CAS  Google Scholar 

  6. Jose A, Crout JR, Kaplan NM: Suppressed renin activity in essential hypertension. Ann Intern Med 1970, 72:9–16.

    CAS  PubMed  Google Scholar 

  7. Spark RF, Melby JC: Hypertension and low plasma renin activity. Presumptive evidence for mineralocorticoid excess. Ann Intern Med 1971, 75:831–836.

    CAS  PubMed  Google Scholar 

  8. Crane MG, Harris JJ, Johns VJ: Hyporeninemic hypertension. Am J Med 1972, 52:457–466.

    Article  CAS  PubMed  Google Scholar 

  9. Carey RM, Douglas JG, Schweikert JR, et al.: The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (Chicago) 1972, 130:849–854.

    CAS  Google Scholar 

  10. Vaughan ED Jr, Laragh JH, Gavras I, et al.: The volume factor in low and normal renin essential hypertension. Its treatment with either spironolactone or chlorthalidone. Am J Cardiol 1973, 32:523–532.

    Article  PubMed  Google Scholar 

  11. Funder JW, Carey RM, Fardella C, et al.: Case detection, diagnosis, and treatment of patients with primary aldosteronism. An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008, 93:3266–3281.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

Dr. Atlas is a member of the Aliskiren Advisory Board and the Aliskiren Speakers Bureau for Novartis, Inc., and his institution received funding from Gilead Sciences for participation in the DORADO trial.

Author information

Authors and Affiliations

  1. James J. Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, NY, 10468, USA

    Steven A. Atlas

Authors
  1. Steven A. Atlas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Atlas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atlas, S.A. Aldosterone to Renin Ratio as a Predictor of Diuretic Response. Curr Hypertens Rep 12, 395–398 (2010). https://doi.org/10.1007/s11906-010-0156-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0156-9

Keywords

Search

Navigation